SLC6A4 and depressive disorder: Due to the major role as a key regulator during serotonergic neurotransmission, 5-HTT represents an important molecular target which is involved in the treatment of neuropsychiatric disorders (e.g. depression, anxiety and post-traumatic stress disorders (PTSD)) [13]–[22].